NBIX vs OGS · P/E 45, rev $2.36B vs P/E 17, rev $2.58B
Neurocrine Biosciences Inc (NBIX) versus One Gas Inc (OGS) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
One Gas Inc (OGS) is a utilities - regulated gas company listed on US.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported OGS revenue for 2022-12-31 was $2.58B. Net income was $221.7M. OGS currently screens at market cap $4.85B and trailing P/E 17.4.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. OGS currently screens at market cap $4.85B and trailing P/E 17.4.
Not investment advice. Open the NBIX and OGS stock pages for the full models.
Not investment advice.